These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36653375)

  • 1. Trends in incident diagnoses and drug prescriptions for anxiety and depression during the COVID-19 pandemic: an 18-month follow-up study based on the UK Biobank.
    Wang Y; Ge F; Wang J; Yang H; Han X; Ying Z; Hu Y; Sun Y; Qu Y; Aspelund T; Hauksdóttir A; Zoega H; Fang F; Valdimarsdóttir UA; Song H
    Transl Psychiatry; 2023 Jan; 13(1):12. PubMed ID: 36653375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study.
    Carr MJ; Steeg S; Webb RT; Kapur N; Chew-Graham CA; Abel KM; Hope H; Pierce M; Ashcroft DM
    Lancet Public Health; 2021 Feb; 6(2):e124-e135. PubMed ID: 33444560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic Medication Use and Psychiatric Disorders During the COVID-19 Pandemic Among Danish Children, Adolescents, and Young Adults.
    Bliddal M; Rasmussen L; Andersen JH; Jensen PB; Pottegård A; Munk-Olsen T; Kildegaard H; Wesselhoeft R
    JAMA Psychiatry; 2023 Feb; 80(2):176-180. PubMed ID: 36515919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of COVID-19 pandemic on anxiety and depression in primary care: A retrospective cohort study.
    Stephenson E; O'Neill B; Kalia S; Ji C; Crampton N; Butt DA; Tu K
    J Affect Disord; 2022 Apr; 303():216-222. PubMed ID: 35139415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic.
    Tiger M; Castelpietra G; Wesselhoeft R; Lundberg J; Reutfors J
    Transl Psychiatry; 2024 Apr; 14(1):175. PubMed ID: 38575574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using Clinical Practice Research Datalink.
    Archer C; MacNeill SJ; Mars B; Turner K; Kessler D; Wiles N
    Br J Gen Pract; 2022 Jul; 72(720):e511-e518. PubMed ID: 35314430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study.
    Raventós B; Pistillo A; Reyes C; Fernández-Bertolín S; Aragón M; Berenguera A; Jacques-Aviñó C; Medina-Perucha L; Burn E; Duarte-Salles T
    BMJ Open; 2022 Apr; 12(4):e057866. PubMed ID: 35396302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Air Pollution, Genetic Susceptibility, and the Risk of Depression and Anxiety: A Prospective Study in the UK Biobank Cohort.
    Gao X; Jiang M; Huang N; Guo X; Huang T
    Environ Health Perspect; 2023 Jan; 131(1):17002. PubMed ID: 36598457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the COVID-19 pandemic on clinically diagnosed psychiatric disorders in persons with type 2 diabetes.
    Kowall B; Kostev K; Landgraf R; Hauner H; Bierwirth R; Rathmann W
    Diabet Med; 2022 Aug; 39(8):e14852. PubMed ID: 35426166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis.
    Yang H; Chen W; Hu Y; Chen Y; Zeng Y; Sun Y; Ying Z; He J; Qu Y; Lu D; Fang F; Valdimarsdóttir UA; Song H
    Lancet Healthy Longev; 2020 Nov; 1(2):e69-e79. PubMed ID: 33521769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriptions of antidepressants and anxiolytics in France 2012-2022 and changes with the COVID-19 pandemic: interrupted time series analysis.
    De Bandt D; Haile SR; Devillers L; Bourrion B; Menges D
    BMJ Ment Health; 2024 Feb; 27(1):. PubMed ID: 38413052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic.
    Shi L; Lu ZA; Que JY; Huang XL; Liu L; Ran MS; Gong YM; Yuan K; Yan W; Sun YK; Shi J; Bao YP; Lu L
    JAMA Netw Open; 2020 Jul; 3(7):e2014053. PubMed ID: 32609353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial experiences of postnatal women during the COVID-19 pandemic. A UK-wide study of prevalence rates and risk factors for clinically relevant depression and anxiety.
    Fallon V; Davies SM; Silverio SA; Jackson L; De Pascalis L; Harrold JA
    J Psychiatr Res; 2021 Apr; 136():157-166. PubMed ID: 33596462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of COVID-19 pandemic on anxiety and depression in primary care: A cohort study in Ontario, Canada.
    Stephenson E; Tu K; Ji C; Butt D; Crampton N; Gronsbell J; O'Neill B
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 35947415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in psychotropic drug consumption among French military personnel during the COVID-19 epidemic.
    Sanchez MA; Fuchs B; Tubert-Bitter P; Mariet AS; Jollant F; Mayet A; Quantin C
    BMC Med; 2022 Sep; 20(1):306. PubMed ID: 36100914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022.
    Wang CX; Kohli R; Olaker VR; Terebuh P; Xu R; Kaelber DC; Davis PB
    Mol Psychiatry; 2024 May; 29(5):1350-1360. PubMed ID: 38238547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription of anxiolytics, sedatives, hypnotics and antidepressants in outpatient, universal care during the COVID-19 pandemic in Portugal: a nationwide, interrupted time-series approach.
    Estrela M; Silva TM; Gomes ER; Piñeiro M; Figueiras A; Roque F; Herdeiro MT
    J Epidemiol Community Health; 2022 Apr; 76(4):335-340. PubMed ID: 34625519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surging trends in prescriptions and costs of antidepressants in England amid COVID-19.
    Rabeea SA; Merchant HA; Khan MU; Kow CS; Hasan SS
    Daru; 2021 Jun; 29(1):217-221. PubMed ID: 33715138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: A cross-sectional study based on UK Biobank.
    Zhang N; Qi X; Chang H; Li C; Qin X; Wei W; Cai Q; He D; Zhao Y; Shi S; Chu X; Wen Y; Jia Y; Zhang F
    J Med Virol; 2023 Apr; 95(4):e28726. PubMed ID: 37185864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.